• Publications
  • Harvard Business Review: How pharma can fix i...
Published on 06 Feb 2017

Harvard Business Review: How pharma can fix its reputation and its business at the same time

Could transforming access to medicine to a fully-fledged business strategy help pharma companies enhance shareholder value? Damiano de Felice, Strategy Director, examines in his article for Harvard Business Review.

Explore further

Back to top |